RAD51D and breast cancer: A total of 38 women in the previously defined low-risk group were reclassified—4 carried a P variant and 34 a VUS in the BARD1, CDH1, MAP3K1, RAD51C, RAD51D, or TP53 gene—none of whom were diagnosed with breast cancer at the time of this study.